[New molecules in 2002].
Vervaeren
Jacques
J
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D001530:Belgium; D017277:Drug Approval; D005260:Female; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy; D011247:Pregnancy
D000890:Anti-Infective Agents; D000927:Anticonvulsants; D006634:Histamine H1 Antagonists; D007004:Hypoglycemic Agents